phosphorylcholine has been researched along with Kidney Diseases in 5 studies
Phosphorylcholine: Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction.
phosphocholine : The phosphate of choline; and the parent compound of the phosphocholine family.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Miltefosine was originally formulated and registered as a topical treatment for cutaneous cancers." | 6.43 | Development of miltefosine as an oral treatment for leishmaniasis. ( Engel, J; Sindermann, H, 2006) |
| "Miltefosine was originally formulated and registered as a topical treatment for cutaneous cancers." | 2.43 | Development of miltefosine as an oral treatment for leishmaniasis. ( Engel, J; Sindermann, H, 2006) |
| "3." | 1.31 | High-resolution magic angle spinning 1H-NMR spectroscopy studies on the renal biochemistry in the bank vole (Clethrionomys glareolus) and the effects of arsenic (As3+) toxicity. ( Griffin, JL; Nicholson, JK; Shore, RF; Walker, L, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bianciardi, P | 1 |
| Brovida, C | 1 |
| Valente, M | 1 |
| Aresu, L | 1 |
| Cavicchioli, L | 1 |
| Vischer, C | 1 |
| Giroud, L | 1 |
| Castagnaro, M | 1 |
| Grönwall, C | 1 |
| Akhter, E | 1 |
| Oh, C | 1 |
| Burlingame, RW | 1 |
| Petri, M | 1 |
| Silverman, GJ | 1 |
| Kamanna, VS | 1 |
| Bassa, BV | 1 |
| Ganji, SH | 1 |
| Roh, DD | 1 |
| Sindermann, H | 1 |
| Engel, J | 1 |
| Griffin, JL | 1 |
| Walker, L | 1 |
| Shore, RF | 1 |
| Nicholson, JK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pharmacokinetics of Miltefosine in Children and Adults: Implications for the Treatment of Cutaneous Leishmaniasis in Colombia.[NCT01462500] | Phase 4 | 60 participants (Actual) | Interventional | 2011-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for phosphorylcholine and Kidney Diseases
| Article | Year |
|---|---|
Bioactive lysophospholipids and mesangial cell intracellular signaling pathways: role in the pathobiology of kidney disease.
Topics: Animals; Cell Proliferation; Glomerular Mesangium; Humans; Kidney Diseases; Lysophosphatidylcholines | 2005 |
Development of miltefosine as an oral treatment for leishmaniasis.
Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Antineoplastic Agents; Antiprotozoal Age | 2006 |
3 other studies available for phosphorylcholine and Kidney Diseases
| Article | Year |
|---|---|
Administration of miltefosine and meglumine antimoniate in healthy dogs: clinicopathological evaluation of the impact on the kidneys.
Topics: Animals; Antiprotozoal Agents; Body Weight; Dogs; Female; Fluorescent Antibody Technique; Histocytoc | 2009 |
IgM autoantibodies to distinct apoptosis-associated antigens correlate with protection from cardiovascular events and renal disease in patients with SLE.
Topics: Adult; Aged; Antibodies, Anti-Idiotypic; Antigens; Apoptosis; Autoantibodies; Cardiovascular Disease | 2012 |
High-resolution magic angle spinning 1H-NMR spectroscopy studies on the renal biochemistry in the bank vole (Clethrionomys glareolus) and the effects of arsenic (As3+) toxicity.
Topics: Alanine; Animals; Arsenic; Arvicolinae; Creatine; Glutamic Acid; Glutamine; Kidney; Kidney Diseases; | 2001 |